Emergence and Utility of Nonspherical Particles in Biomedicine.

The importance of the size of targeted, spherical drug carriers has been previously explored and reviewed. Particle shape has emerged as an equally important parameter in determining the in vivo journey and efficiency of drug carrier systems. Researchers have invented techniques to better control the geometry of particles of many different materials, which have allowed for exploration of the role of particle geometry in the phases of drug delivery. The important biological processes include clearance by the immune system, trafficking to the target tissue, margination to the endothelial surface, interaction with the target cell, and controlled release of a payload. The review of current literature herein supports that particle shape can be altered to improve a system's targeting efficiency. Non-spherical particles can harness the potential of targeted drug carriers by enhancing targeted site accumulation while simultaneously decreasing side effects and mitigating some limitations faced by spherical carriers.

[1]  A. Borhan,et al.  Microencapsulation of Chemotherapeutics into Monodisperse and Tunable Biodegradable Polymers via Electrified Liquid Jets: Control of Size, Shape, and Drug Release , 2013, Advanced materials.

[2]  Li Shi,et al.  Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[4]  Yajun Wang,et al.  Shape-dependent cellular processing of polyelectrolyte capsules. , 2013, ACS nano.

[5]  Efstathios Karathanasis,et al.  The effects of particle size, density and shape on margination of nanoparticles in microcirculation , 2011, Nanotechnology.

[6]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[7]  Samir Mitragotri,et al.  Shape Induced Inhibition of Phagocytosis of Polymer Particles , 2008, Pharmaceutical Research.

[8]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[9]  Mary E Napier,et al.  The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[11]  X. Zhao,et al.  Lithographically defined uniform worm-shaped polymeric nanoparticles , 2010, Nanotechnology.

[12]  Nicholas Melosh,et al.  Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. , 2012, Nano letters.

[13]  Samuel Zalipsky,et al.  Chemistry of polyethylene glycol conjugates with biologically active molecules , 1995 .

[14]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[15]  Joseph M DeSimone,et al.  Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[16]  M. Morris,et al.  PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions , 2013 .

[17]  Walter Hu,et al.  Shape-specific polymeric nanomedicine: emerging opportunities and challenges , 2011, Experimental biology and medicine.

[18]  Dhananjay Dendukuri,et al.  Stop-flow lithography in a microfluidic device. , 2007, Lab on a chip.

[19]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[20]  Sei-Young Lee,et al.  Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.

[21]  Supriya Mocherla,et al.  In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis. , 2014, Atherosclerosis.

[22]  L. Tong,et al.  Cellular binding and internalization of functionalized silicon nanowires. , 2012, Nano letters.

[23]  Gerhard Gompper,et al.  Margination of micro- and nano-particles in blood flow and its effect on drug delivery , 2014, Scientific Reports.

[24]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[25]  Jinming Gao,et al.  Modeling particle shape-dependent dynamics in nanomedicine. , 2011, Journal of nanoscience and nanotechnology.

[26]  Amir Houshang Bahrami,et al.  Orientational changes and impaired internalization of ellipsoidal nanoparticles by vesicle membranes , 2013 .

[27]  Phapanin Charoenphol,et al.  Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.

[28]  Ken Donaldson,et al.  Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro , 2012, Particle and Fibre Toxicology.

[29]  A. Ray,et al.  Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. , 2011, International journal of pharmaceutics.

[30]  Mauro Ferrari,et al.  Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.

[31]  S. Mitragotri,et al.  Endocytosis and Intracellular Distribution of PLGA Particles in Endothelial Cells: Effect of Particle Geometry. , 2010, Macromolecular rapid communications.

[32]  Dennis E Discher,et al.  Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. , 2009, Molecular pharmaceutics.

[33]  E. Tomlinson Theory and practice of site-specific drug delivery , 1987 .

[34]  Paolo Decuzzi,et al.  On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better , 2013, Scientific Reports.

[35]  Michael J Sailor,et al.  Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. , 2009, Small.

[36]  Samir Mitragotri,et al.  Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[37]  James E Bear,et al.  PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. , 2012, Nano letters.

[38]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Shapiro,et al.  Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity , 1998, Journal of Fluid Mechanics.

[40]  O. Eniola-Adefeso,et al.  The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow. , 2013, Biomaterials.

[41]  F. Millero,et al.  Conditions for the occurrence of large near-wall excesses of small particles during blood flow. , 1988, Microvascular research.

[42]  S. Bhatia,et al.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging , 2008, Advanced materials.

[43]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[44]  M. Cesta Normal Structure, Function, and Histology of the Spleen , 2006, Toxicologic pathology.

[45]  Huub Schellekens,et al.  Immunological Risk of Injectable Drug Delivery Systems , 2009, Pharmaceutical Research.

[46]  M. Walsh,et al.  Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[47]  Michael S. Goldberg,et al.  Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[48]  Zongxi Li,et al.  Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. , 2011, ACS nano.

[49]  Phapanin Charoenphol,et al.  Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[50]  M. Perry,et al.  Hepatotoxicity of chemotherapy. , 2006, The oncologist.

[51]  T. A. Hatton,et al.  Synthesis of nonspherical superparamagnetic particles: in situ coprecipitation of magnetic nanoparticles in microgels prepared by stop-flow lithography. , 2012, Journal of the American Chemical Society.

[52]  H. Santos,et al.  Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods. , 2011, Journal of pharmaceutical sciences.

[53]  J. Skepper,et al.  The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages☆ , 2014, Biomaterials.

[54]  G. Gompper,et al.  Shape and orientation matter for the cellular uptake of nonspherical particles. , 2014, Nano letters.

[55]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[56]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[57]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[58]  M. Heslinga,et al.  One-step fabrication of agent-loaded biodegradable microspheroids for drug delivery and imaging applications. , 2014, Colloids and surfaces. B, Biointerfaces.

[59]  Wei-Hsin Hsu,et al.  Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[60]  S. Mitragotri,et al.  Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. , 2011, Advanced drug delivery reviews.

[61]  Mauro Ferrari,et al.  Dissipative particle dynamics simulation of circular and elliptical particles motion in 2D laminar shear flow , 2011 .

[62]  Daan Frenkel,et al.  Receptor-mediated endocytosis of nanoparticles of various shapes. , 2011, Nano letters.

[63]  Cuifang Cai,et al.  PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery. , 2014, Molecular pharmaceutics.

[64]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[65]  A. Jones,et al.  Nanoparticle geometry and surface orientation influence mode of cellular uptake. , 2013, ACS nano.

[66]  Shaoyi Jiang,et al.  Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. , 2011, Nature chemistry.

[67]  L. Yang,et al.  Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. , 1996, Journal of pharmaceutical sciences.

[68]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[69]  D. Underhill,et al.  Information processing during phagocytosis , 2012, Nature Reviews Immunology.

[70]  Mauro Ferrari,et al.  Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.

[71]  S. Mitragotri,et al.  Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.

[72]  P. Devarajan,et al.  Particle shape: a new design parameter for passive targeting in splenotropic drug delivery. , 2010, Journal of pharmaceutical sciences.

[73]  A. Tilles,et al.  The near-wall excess of platelet-sized particles in blood flow: its dependence on hematocrit and wall shear rate. , 1987, Microvascular research.

[74]  V. Kozlovskaya,et al.  Biocompatible shaped particles from dried multilayer polymer capsules. , 2013, Biomacromolecules.

[75]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[76]  Clemens Burda,et al.  Nanoparticle mediated non-covalent drug delivery. , 2013, Advanced drug delivery reviews.

[77]  V. Diéras,et al.  Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[78]  Jürgen Groll,et al.  Phagocytosis independent extracellular nanoparticle clearance by human immune cells. , 2010, Nano letters.

[79]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[80]  M Ferrari,et al.  The adhesive strength of non-spherical particles mediated by specific interactions. , 2006, Biomaterials.

[81]  S. Moghimi Mechanisms of splenic clearance of blood cells and particles : towards development of new splenotropic agents , 1995 .

[82]  Matthew D. McDermott,et al.  The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[84]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[85]  M Ferrari,et al.  The receptor-mediated endocytosis of nonspherical particles. , 2008, Biophysical journal.

[86]  Stuart Williams,et al.  Microfabricated Engineered Particle Systems for Respiratory Drug Delivery and Other Pharmaceutical Applications , 2012, Journal of drug delivery.

[87]  C. Pozrikidis,et al.  Orbiting motion of a freely suspended spheroid near a plane wall , 2005, Journal of Fluid Mechanics.

[88]  S. V. Sreenivasan,et al.  Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms , 2013, Proceedings of the National Academy of Sciences.

[89]  Khellil Sefiane,et al.  Experimental investigation of self-induced thermocapillary convection for an evaporating meniscus in capillary tubes using micro-PIV , 2005 .

[90]  T. Boulikas Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin , 2009, Expert opinion on investigational drugs.

[91]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[93]  T. Niidome,et al.  Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice , 2012, Nanoscale Research Letters.

[94]  D. Pinsky,et al.  Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters. , 2011, Atherosclerosis.

[95]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[96]  Changyou Gao,et al.  Fabrication of biconcave discoidal silica capsules and their uptake behavior by smooth muscle cells. , 2014, Journal of colloid and interface science.

[97]  H. Kong,et al.  Ellipsoidal Polyaspartamide Polymersomes with Enhanced Cell‐Targeting Ability , 2012, Advanced functional materials.

[98]  Samir Mitragotri,et al.  Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[99]  M. Chan-Park,et al.  Effect of particle shape on phagocytosis of CdTe quantum dot–cystine composites , 2010 .

[100]  Samir Mitragotri,et al.  Macrophages Recognize Size and Shape of Their Targets , 2010, PloS one.

[101]  M Ferrari,et al.  The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. , 2008, Journal of biomechanics.

[102]  A. Gerbes,et al.  Role of Kupffer cells in host defense and liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[103]  Y. Li,et al.  Zero-order drug release cellulose acetate nanofibers prepared using coaxial electrospinning , 2013, Cellulose.

[104]  Kai Yang,et al.  Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. , 2010, Nature nanotechnology.

[105]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[106]  Samir Mitragotri,et al.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.